Back to news January 2019

San Francisco, Calif., January 15, 2019 – endpoint Clinical, an industry-leading global interactive response technology (IRT) company, has appointed Catherine Hall as its VP, Product Strategy.  Bringing 17 years of Clinical Supply Chain experience, Catherine will drive endpoint’s global product strategy, including product vision, product execution, team development, and product culture.

“When I was introduced to endpoint in 2012 it was obvious that they were about to change the way we thought about IRT as an industry,” says Hall.  “In working with them over the years they have proven how to take an idea, including my own, and make it a reality.  Today the world has never been more focused on data, and clinical trials are demanding us to change the way we think about it.  That is why I am truly ecstatic to join endpoint and lead their product strategy.  Through collaboration and innovation, I hope we might further shape the future of IRT and secure the future of clinical trials.”

Hall began her career as an academic scientist in Molecular and Cellular Biology before finishing her MBA and transitioning into Supply Chain working with Pfizer/ Millennium/Takeda, Biogen/ Alnylam and Sunovion.  During her career, she has developed training programs, led process improvement initiatives, and helped build partnerships and solidify alliances.  Catherine is most well known for her focus on bridging the GMP/GCP gap to bring supply chain customer service through the last mile to patients.

Hall’s most recent role was the Director of Operational Excellence in the Office of R&D Strategic Planning at Sunovion Pharmaceuticals.  She is also an active member of the Investigational Products community as a member of the New England Clinical Supply Organization Steering Committee and is the current Chair of the North America ISPE Investigational Products Community of Practice.

“While we constantly exercise the value of customer obsession at endpoint, we feel that bringing Catherine on board from the Sponsor side will ensure that we are looking through the lens of the users even deeper than we ever have before,” says Christine Oliver, COO.  “This will guarantee that we’re continuing to drive our products forward to meet the ongoing needs of the Sponsors and investigator sites using our products, allowing them more time to focus on what’s most important – the patient.”

Read more about endpoint’s solutions at

About endpoint

endpoint is an interactive response technology (IRT®) systems and solutions provider that supports the life sciences industry.  Since 2009, we have been working with a single vision in mind, to help sponsors and pharmaceutical companies achieve clinical trial success.  Our solutions, realized through the proprietary PULSE® platform, have proven to maximize the supply chain, minimize operational costs, and ensure timely and accurate patient dosing.  endpoint is headquartered in San Francisco, California, with offices across the United States, Europe, and Asia.